Down Syndrome: Regenerative Medicine Taming the Over-Expressive Trisomy (Chromosome 21) Genes

Journal Title: Journal of Regenerative Biology and Medicine - Year 2020, Vol 2, Issue 5

Abstract

Trisomy silencing is an important factor in curing Down syndrome. As per a study in various experiments, XIST Transgene transforms chromosome 21 in stem cells. This Transgene normalizes cell function and development upon transformation and its induction in Transgene clones corrects the overproduction of meakayocytes, stemcells, iPS cells and erythrocytes keeping the balance of hemopoietic developments. Given all these to added knowledge, our study further advanced to CD4/CD43 progenitors cells demonstrating principle proof for epigenetic based investigative strategy in pathology. Chapter basic focuses on drug discovery, delivery of drugs, administration path, dosage and frequency of transplantation. Monitor tools of MRI, MSK and PET-CT scanners. Also,the cultivation of chromosome 21 cells trisomy to disomy is relevant without genetic manipulation, chemical treatment and exposure to irradiation. Disomy or diploid cells serve to the purpose of drug screening and raw material of regenerative medicine and cell-based therapy.

Authors and Affiliations

Prithiv KR Kumar1*and Albert Alukal2

Keywords

Related Articles

Preliminary Experience of Video Conferences in Pediatrics in Covid-19 Pandemic

A video conference enables real-time exchange between two or more participants at different locations via audio and video communication. In terms of the visualization of the discussion partners, a videoconference thus di...

Allogenic Human Umbilical Cord Derived Mesenchymal Stem Cells for Managing Knee Osteoarthritis in Human - A Clinical Trial

Introduction: Human Mesenchymal Stem Cell has been scientifically accepted as a method of managing Osteoarthritis in the Human knee. They can be derived from Autologous Bone Marrow, Adipose Tissue, and less commonly Syno...

Effect of Salvestrol as an Adjunct in the Treatment of Head & Neck, GIT, Ovary, Breast and Lung Malignancies Undergoing Conventional Treatment in an Indian Population

Background: Previous studies have elucidated that Salvestrols are a class of phytonutrients that, function through an extremely targeted mechanism that hinges on their metabolism by the universal cancer marker CYP1B1, ca...

Front-line Healthcare Workers in COVID-19: The way from Elbow-Bump Greeting to Closing Body Bags

COVID-19 is a serious coronavirus disease that is spreading all over the world. As of the date of this publication, 2.834.134 people have been infected with COVID-19 and 197.924 deaths have been recorded in 185 countries...

Homologous Use of Umbilical Cord Tissue for Knee Pain

Context: Injection with homologously-used umbilical cord tissue allograft has not been adequately studied in patients suffering from knee pain. Objectives: The goal of this study is to determine if knee pain subjects...

Download PDF file
  • EP ID EP707343
  • DOI https://doi.org/10.37191/Mapsci-2582-385X-2(5)-040
  • Views 44
  • Downloads 0

How To Cite

Prithiv KR Kumar1*and Albert Alukal2 (2020). Down Syndrome: Regenerative Medicine Taming the Over-Expressive Trisomy (Chromosome 21) Genes. Journal of Regenerative Biology and Medicine, 2(5), -. https://europub.co.uk/articles/-A-707343